EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Recent Advances and Future Directions in Bladder Preservation Therapy for Muscle‐Invasive Bladder Cancer

Tomokazu Kimura iD, Satoshi Inoue iD, Tomoyasu Sano, Kenji Zennami, Shusuke Akamatsu

International Journal of Urology · 2025

DOI: 10.1111/iju.70164 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Urology, 2025. Verfasst von Tomokazu Kimura und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Organ Sparing Treatments. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bladder preservation therapy has emerged as an essential alternative to radical cystectomy for muscle‐invasive bladder cancer, particularly in elderly or frail patients. Trimodal therapy, combining maximal transurethral resection of bladder tumors, chemotherapy, and radiotherapy, has shown comparable oncological outcomes to radical cystectomy in selected cases. Recent advances in radiotherapy techniques and systemic therapies, including immune checkpoint inhibitors, have expanded the role of bladder‐preserving strategies in the management of bladder cancer. Clinical trials investigating various combinations of radiotherapy, chemotherapy, and immune checkpoint inhibitors have redefined the treatment landscape. Observational studies have reported survival outcomes comparable to those of radical cystectomy, along with improved quality‐adjusted life years. Emerging therapeutic strategies offer additional potential for improving outcomes. Bladder preservation therapy continues to evolve, with future approaches aimed at enhancing survival while preserving the quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsOrgan Sparing TreatmentsHumansCystectomyNeoplasm InvasivenessQuality of LifeUrinary BladderCombined Modality TherapyTreatment OutcomeImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

chemoradiotherapyclinical trials as topicimmune checkpoint inhibitorsorgan sparing treatmentsurinary bladder neoplasms

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

ORCID-Profile: Tomokazu Kimura, Satoshi Inoue

Zitieren

APA

Kimura, T., Inoue, S., Sano, T., Zennami, K., & Akamatsu, S. (2025). Recent Advances and Future Directions in Bladder Preservation Therapy for Muscle‐Invasive Bladder Cancer. International Journal of Urology. https://doi.org/10.1111/iju.70164

Vancouver

Kimura T, Inoue S, Sano T, Zennami K, Akamatsu S. Recent Advances and Future Directions in Bladder Preservation Therapy for Muscle‐Invasive Bladder Cancer. International Journal of Urology. 2025. doi:10.1111/iju.70164

BibTeX
@article{Kimura2025,
  author = {Kimura, Tomokazu and Inoue, Satoshi and Sano, Tomoyasu and Zennami, Kenji and Akamatsu, Shusuke},
  title = {Recent Advances and Future Directions in Bladder Preservation Therapy for Muscle‐Invasive Bladder Cancer},
  journal = {International Journal of Urology},
  year = {2025},
  doi = {10.1111/iju.70164}
}
Kostenlos starten →